Case Study

Proof of Concept: Virtual Site Selection Visit (SSV)

Format: PDF file | Document type: Case Study | Promoted Content

This content is provided by Signant Health, and any views and opinions expressed do not necessarily reflect those of

Proof of Concept: Virtual Site Selection Visit (SSV)

The recent pandemic inspired Bayer to a proof-of-concept (POC) study that identified a viable solution for replacing in-person site selection visits. The big pharma company hoped that in doing so, their CRAs could remotely complete monitoring activities related to selection, initiation, monitoring, and closeout.

Bayer chose to try Signant Health’s Virtual Monitoring solution to:

  • Find a safe alternative to on-site visits
  • Assess if the tool streamlined site assessments
  • Determine if virtual SSVS could be performed without compromising the visit quality

Read the case study to learn the encountered challenges and final results.

Latest content from Signant Health

Scaling up eConsent

Paid for and content provided by Signant Health

Scaling up eConsent

The informed consent process is fundamental to every clinical trial. Study participants must be provided with sufficient information to understand the study, its procedures and commitments, the possible treatments they may receive, and any possible risks...

Related resources from Signant Health

Show more

Supplier info centre